{"id":"https://openalex.org/W1970684135","doi":"https://doi.org/10.1089/10430349950018030","title":"Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy","display_name":"Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy","publication_year":1999,"publication_date":"1999-05-20","ids":{"openalex":"https://openalex.org/W1970684135","doi":"https://doi.org/10.1089/10430349950018030","mag":"1970684135","pmid":"https://pubmed.ncbi.nlm.nih.gov/10365666"},"language":"en","primary_location":{"id":"doi:10.1089/10430349950018030","doi":"https://doi.org/10.1089/10430349950018030","is_oa":false,"landing_page_url":"https://doi.org/10.1089/10430349950018030","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064040222","display_name":"Ying K. Tam","orcid":"https://orcid.org/0000-0002-4083-5251","observed_orcids":["https://orcid.org/0000-0002-4083-5251"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Y.K. Tam","raw_affiliation_strings":["Division of Hematology, Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada. ytam@rush.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada. ytam@rush.edu","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063292795","display_name":"Guitta Maki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Maki","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012761025","display_name":"Blythe Miyagawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Miyagawa","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054422040","display_name":"Burkhard Hennemann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Hennemann","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050893255","display_name":"Torsten Tonn","orcid":"https://orcid.org/0000-0001-9580-2193","observed_orcids":["https://orcid.org/0000-0001-9580-2193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Tonn","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111951054","display_name":"Hans Klingemann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.-G. Klingemann","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5966,"has_fulltext":false,"cited_by_count":203,"citation_normalized_percentile":{"value":0.82531453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"10","issue":"8","first_page":"1359","last_page":"1373"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nk-92-cells","display_name":"NK-92 cells","score":0.875},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8560000061988831},{"id":"https://openalex.org/keywords/adoptive-cellular-immunotherapy","display_name":"adoptive cellular immunotherapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/particle-mediated-gene-transfer","display_name":"particle-mediated gene transfer","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.8230000138282776},{"id":"https://openalex.org/keywords/radiosensitivity","display_name":"radiosensitivity","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hematopoietic-progenitor-cells","display_name":"hematopoietic progenitor cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cancer-cell-lines","display_name":"cancer cell lines","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7667723298072815},{"id":"https://openalex.org/C149532602","wikidata":"https://www.wikidata.org/wiki/Q2409681","display_name":"Interleukin 12","level":4,"score":0.7203179597854614},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.6312685012817383},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5867113471031189},{"id":"https://openalex.org/C28651165","wikidata":"https://www.wikidata.org/wiki/Q4259786","display_name":"Lymphokine-activated killer cell","level":5,"score":0.5847647190093994},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5681469440460205},{"id":"https://openalex.org/C98119934","wikidata":"https://www.wikidata.org/wiki/Q14907167","display_name":"Interleukin 15","level":4,"score":0.550244152545929},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.49862194061279297},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.48006948828697205},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.47370645403862},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.4680824875831604},{"id":"https://openalex.org/C131665280","wikidata":"https://www.wikidata.org/wiki/Q14866169","display_name":"Interleukin 3","level":5,"score":0.4650462865829468},{"id":"https://openalex.org/C183315844","wikidata":"https://www.wikidata.org/wiki/Q6155969","display_name":"Janus kinase 3","level":5,"score":0.45986342430114746},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.4440787732601166},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.42566749453544617},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4253690838813782},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4120592176914215},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35292279720306396},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33666640520095825},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.26127368211746216},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2512969374656677},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1829080879688263},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07836931943893433}],"mesh":[{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D020014","descriptor_name":"K562 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/10430349950018030","doi":"https://doi.org/10.1089/10430349950018030","is_oa":false,"landing_page_url":"https://doi.org/10.1089/10430349950018030","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"},{"id":"pmid:10365666","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10365666","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human gene therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W39910466","https://openalex.org/W76522298","https://openalex.org/W105259630","https://openalex.org/W109340176","https://openalex.org/W166073194","https://openalex.org/W175021650","https://openalex.org/W307339191","https://openalex.org/W348089281","https://openalex.org/W1495399046","https://openalex.org/W1504415792","https://openalex.org/W1527330207","https://openalex.org/W1556149314","https://openalex.org/W1616824889","https://openalex.org/W1825190281","https://openalex.org/W1826995994","https://openalex.org/W1976805459","https://openalex.org/W1979230120","https://openalex.org/W1989642122","https://openalex.org/W2018227907","https://openalex.org/W2027151931","https://openalex.org/W2027160253","https://openalex.org/W2030274505","https://openalex.org/W2048203018","https://openalex.org/W2059477195","https://openalex.org/W2062822032","https://openalex.org/W2077163532","https://openalex.org/W2078923181","https://openalex.org/W2084398206","https://openalex.org/W2085781143","https://openalex.org/W2087553718","https://openalex.org/W2119779707","https://openalex.org/W2124341258","https://openalex.org/W2124446900","https://openalex.org/W2124779813","https://openalex.org/W2135808990","https://openalex.org/W2143381422","https://openalex.org/W2154767421","https://openalex.org/W2172871346","https://openalex.org/W2279123984","https://openalex.org/W2383431684","https://openalex.org/W2410504189","https://openalex.org/W2411295760","https://openalex.org/W2414951805","https://openalex.org/W2415485186","https://openalex.org/W2420284819","https://openalex.org/W2916269123"],"related_works":["https://openalex.org/W39910466","https://openalex.org/W2578091245","https://openalex.org/W2907916603","https://openalex.org/W1584288161","https://openalex.org/W2229058835","https://openalex.org/W4297004504","https://openalex.org/W2415485186","https://openalex.org/W7099589792","https://openalex.org/W4319432298","https://openalex.org/W2582989999"],"abstract_inverted_index":{"NK-92":[0,40,89,108,177,212],"is":[1,30,76],"a":[2,45],"highly":[3],"cytotoxic":[4,70,225],"natural":[5,249],"killer":[6,250],"(NK)":[7],"tumor":[8],"cell":[9,90,154],"line":[10,91],"that":[11,14,200,213],"possesses":[12],"properties":[13],"make":[15],"it":[16],"an":[17],"excellent":[18],"candidate":[19],"for":[20,44,236,255],"adoptive":[21],"cellular":[22],"immunotherapy.":[23],"However,":[24],"the":[25,84,87,128,149,253],"cytotoxicity":[26,43,150,191],"of":[27,49,86,151,211,230],"NK":[28],"cells":[29,41,61,71,137,172,218,232,241,251],"dependent":[31],"on":[32],"cytokines":[33],"such":[34],"as":[35],"interleukin":[36],"2":[37],"(IL-2).":[38],"Although":[39],"maintain":[42],"time":[46],"after":[47],"withdrawal":[48],"IL-2,":[50],"clinical":[51,237],"use":[52],"will":[53],"probably":[54],"require":[55],"prolonged":[56,244],"treatment":[57,245],"with":[58,72,92,116,139,142,160,179,193,246],"fully":[59,247],"activated":[60],"to":[62,68,101,123,216],"eliminate":[63],"disease":[64],"effectively.":[65],"The":[66,227],"ability":[67],"support":[69],"exogenously":[73],"administered":[74],"IL-2":[75,94,131,257],"limited":[77],"by":[78,97,204],"associated":[79],"toxicity.":[80],"Therefore,":[81],"we":[82,201],"describe":[83,111],"transfection":[85,229],"IL-2-dependent":[88],"human":[93],"(hIL-2)":[95],"cDNA":[96],"particle-mediated":[98,205],"gene":[99,206],"transfer":[100,207],"create":[102],"two":[103,208],"IL-2-independent":[104,161,209,240],"variants,":[105],"NK-92MI":[106,136,169],"and":[107,110,114,126,158,170,186,189],"CI,":[109],"their":[112],"characterization":[113],"comparison":[115],"parental":[117,146,194,217],"cells.":[118,147,168,195],"Both":[119],"variants":[120,162,210],"were":[121,173],"shown":[122],"contain,":[124],"express,":[125],"synthesize":[127],"hIL-2":[129],"cDNA.":[130],"synthesis":[132],"was":[133,156],"higher":[134],"in":[135,145,219],"compared":[138,192],"NK-92CI":[140,171],"cells,":[141,178],"no":[143],"expression":[144],"Functionally,":[148],"all":[152,221],"three":[153],"lines":[155],"similar":[157],"coincubation":[159],"did":[163],"not":[164],"affect":[165],"hematopoietic":[166],"progenitor":[167],"more":[174],"radiosensitive":[175],"than":[176],"proliferation":[180],"inhibited":[181],"at":[182],"lower":[183],"radiation":[184],"doses":[185],"increased":[187],"morality":[188],"decreased":[190],"Data":[196],"presented":[197],"here":[198],"show":[199],"have":[202],"created":[203],"are":[214],"identical":[215],"virtually":[220],"respects,":[222],"including":[223],"high":[224],"activity.":[226],"nonviral":[228],"these":[231],"makes":[233],"them":[234],"suitable":[235],"applications.":[238],"These":[239],"should":[242],"allow":[243],"active":[248],"without":[252],"need":[254],"exogenous":[256],"support.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}